Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableLooking for participantsNCT06024837What this trial is testingPerformance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre StudyWho this might be right forColo-rectal Cancer Centre Hospitalier Universitaire de Saint Etienne 100
Early research (Phase 1)Active Not RecruitingNCT04220827What this trial is testingPaclitaxel for the Treatment of Gastric or Gastroesophageal CancerWho this might be right forClinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8+14 more M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00126542What this trial is testingBevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer+1 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)UnknownNCT04475159What this trial is testingCombined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II TrialWho this might be right forMetastatic Colorectal CancerPeritoneal CarcinomatosisColon Adenocarcinoma Prof. Aviram Nissan 50
Testing effectiveness (Phase 2)Study completedNCT00551070What this trial is testingSelumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerWho this might be right forBorderline Ovarian Serous TumorLow Grade Ovarian Serous AdenocarcinomaMicropapillary Serous Carcinoma+3 more National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06295094What this trial is testingThe Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.Who this might be right forGastric CancerChemotherapy, AdjuvantPeritoneal Metastases+1 more Odense University Hospital 264
Early research (Phase 1)Study completedNCT01065662What this trial is testingAZD2171 and Temsirolimus in Patients With Advanced Gynecological MalignanciesWho this might be right forEndometrial CancerOvarian CancerCervical Cancer+2 more Susana M. Campos, MD 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05446298What this trial is testingONC-392 and Pembrolizumab in Platinum Resistant Ovarian CancerWho this might be right forOvarian CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+1 more OncoC4, Inc. 58
Testing effectiveness (Phase 2)Looking for participantsNCT06730347What this trial is testingLorigerlimab in Participants With Advanced Solid TumorsWho this might be right forPlatinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+8 more MacroGenics 80
Testing effectiveness (Phase 2)Study completedNCT03783949What this trial is testingEuropean Trial on Enhanced DNA Repair Inhibition in Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma Universitaire Ziekenhuizen KU Leuven 122
Early research (Phase 1)Ended earlyNCT02948426What this trial is testingIntraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04575961What this trial is testingStudy of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian CancerWho this might be right forOvarian CancerLow Grade Serous CarcinomaPrimary Peritoneal Carcinoma+1 more North Eastern German Society of Gynaecological Oncology 33
Not applicableStudy completedNCT00801320What this trial is testingPrimary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal CancerFallopian Tube Cancer Beth Israel Deaconess Medical Center 100
Early research (Phase 1)Study completedNCT00003450What this trial is testingGene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486310What this trial is testingEvaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled TrialWho this might be right forAdvanced Gastric Cancer Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01681368What this trial is testingBirinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal CancerWho this might be right forEpithelial Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms National Cancer Institute (NCI) 11
Early research (Phase 1)Study completedNCT00803569What this trial is testingVaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancersWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Ludwig Institute for Cancer Research 13
Testing effectiveness (Phase 2)Study completedNCT00466986What this trial is testingAbraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Southeastern Gynecologic Oncology 40
Large-scale testing (Phase 3)Study completedNCT00003322What this trial is testingCombination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 384